The pharmaceutical industry seems besieged on all sides by declining R&D productivity, expiring patents and relentless downward pricing pressure. One effect of this onslaught has been an upsurge in the level of consolidation as industry players attempt to cut costs, expand research pipelines and lengthen geographic reach.
12-Dec-2013 - Algorithme Pharma has increased early stage patient access by teaming with a Montreal hospital, and says it provides a breadth of therapeutic areas not normally associated with mid-sized CROs.
10-Dec-2013 - Venn Life Sciences has purchased Belfast, UK CRO Medevol in its second acquisition in as many months.
03-Dec-2013 - Soon to merge CMO Patheon has increased solid dosage form production capacity at its site in the UK and posted an improved set of preliminary results for the financial year.
02-Dec-2013 - Strategic partnerships are “the next phase” of sponsor-CRO relations, according to Parexel, and on top of saving pharma on oversight costs will reshape the industry.
02-Dec-2013 - Private equity will be looking to exit the CRO industry and could pose a threat to recent strong growth, according to financial experts at PCT
02-Dec-2013 - Trust, transparency and end-to-end participation are just some of the reasons Merck Serono says its exclusive strategic partnership with Quintiles is the “first of its kind.”
18-Nov-2013 - Venn Life Sciences has broadened its global footprint with the acquisition of a German CRO and says it is looking for more growth opportunities.
13-Nov-2013 - US CRO PRA International has announced plans to buy privately-owned early phase trial specialist CRI Lifetree.
29-Oct-2013 - inVentiv Health has opened a new UK office in order to better target European customers, whilst Novum says its North Dakota facility will strengthen its offerings.
28-Oct-2013 - CDMO Aenova has continued its strategy of consolidation with the acquisition of Haupt Pharma.
28-Oct-2013 - McKesson Group has completed the acquisition of logistics firm Celesio as it eyes a global strategy, targeting the European and Latin America markets.
22-Oct-2013 - Sponsor network developer DrugDev on Monday announced it would acquire CFS Clinical, which specializes in managing the financing of clinical trials. Financial terms were not disclosed.
17-Oct-2013 - US contractor DPT says it has received calls from customers of soon-to-close CMO Ben Venue Labs.
10-Oct-2013 - Catalent has continued its softgel expansion in emerging markets with the acquisition of Relthy Laboratórios in Brazil.
10-Oct-2013 - McKesson Corporation who is said to be in talks to acquire German logistics company Celesio has appointed a new CFO and Executive Director - Welcome to Outsourcing-Pharma's People on the Move....
08-Oct-2013 - AAIPharma says the merger with Cambridge Major Laboratories (CML) will bring clients the benefits of integrated Chemistry and Manufacturing Controls (CMC) services from two high-growth CMOs.
26-Sep-2013 - WCCT Global has acquired OC Clinical Trials & Consulting to boost its early-stage ophthalmology services and fill a gap in the market, the firm says.
25-Sep-2013 - The merger of PRA and RPS has been completed, creating the fourth largest contract research organisation (CRO).
24-Sep-2013 - Molecular Profiles has been chosen to develop topical and solid dose formulations of a preclinical psoriasis treatment as part of a multicompany conglomerate led by Telormedix.
17-Sep-2013 - Recent entrant into the formulation services sector Columbia Laboratories has added Molecular Profiles execs to its board.
10-Sep-2013 - The CMO market remains highly fragmented with thirty percent of active players likely to exit the business in the next ten years, according to a Frost & Sullivan report.
09-Sep-2013 - Patheon has reported increased revenue growth for Q3 2013 following the full completion of Banner and says more industry consolidation is likely.
30-Jul-2013 - US CRO Crown BioSciences has acquired Precos citing the UK contractor’s preclinical oncology services and presence in the European market as the key drivers.
25-Jul-2013 - Clinical Research Advantage (CRA) has acquired the late phase business of Comprehensive Clinical Development (CCD) adding psychiatric clinical trials to its services.
05-Mar-2013 - US CRO PRA international has expanded its presence in Eastern Europe with the acquisition of privately-owned trial services firm ClinStar.